Major Ingredients

Amoxycillin BP + clavulanic acid USP (125mg+31.25mg/5ml) suspension.

Major Functionality

Demoxiclave is indicated for shortterm treatment of bacterial infections at the following sites : Upper respiratory tract infections (including ENT) e.g. tonsillitis, sinusitis, otitis media. Lower respiratory tract infections e.g. acute and chronic bronchitis, lobar and bronchopneumonia. Genito-urinary tract infections e.g. cystitis, urethritis, pyelonephritis. Skin and soft tissue infections. Bone and joint infections e.g. osteomyelitis.Other infections e.g. septic abortion, puerperal sepsis, intra-abdominal sepsis, etc.

Manufacture Information

Drug International Limited was incorporated under the Registrar of Joint Stock Companies in 1974 as a Private Limited Company. The company commenced formulation and production in 1983 and emerged as a pioneer in Bangladesh for adding a state of the art oral solid dosage plant. Since inception, Drug International Limited's primary objective has been to meet guidelines provided by major global regulatory bodies such as the World Health Organization Good Manufacturing Practices (WHO cGMP) guidelines.